-
1
-
-
0030930147
-
Disease recurrence after resection for stage I lung cancer
-
DOI 10.1016/S1010-7940(97)00198-X, PII S101079409700198X
-
Al-Kattan K, Sepsas E, Fountain SW and Townsend ER: Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 12: 380-384, 1997. (Pubitemid 27397975)
-
(1997)
European Journal of Cardio-thoracic Surgery
, vol.12
, Issue.3
, pp. 380-384
-
-
Al-Kattan, K.1
Sepsas, E.2
Fountain, S.W.3
Townsend, E.R.4
-
2
-
-
78049385145
-
Association between lymphangiogenesis-/ micrometastasis- and adhesion-related molecules in resected stage I NSCLC
-
in press
-
Yamashita T, Uramoto H, Onitsuka T, Ono K, Baba T, So T, So T, Takenoyama M, Hanagiri T, Oyama T and Yasumoto K: Association between lymphangiogenesis-/ micrometastasis- and adhesion-related molecules in resected stage I NSCLC. Lung Cancer in press.
-
Lung Cancer
-
-
Yamashita, T.1
Uramoto, H.2
Onitsuka, T.3
Ono, K.4
Baba, T.5
So, T.6
So, T.7
Takenoyama, M.8
Hanagiri, T.9
Oyama, T.10
Yasumoto, K.11
-
3
-
-
79955482651
-
TS expression predicts postoperative recurrence in adenocarcinoma of the lung
-
in press
-
Shimokawa H, Uramoto H, Onitsuka T, Iwata T, Nakagawa M, Ono K and Hanagiri T: TS expression predicts postoperative recurrence in adenocarcinoma of the lung. Lung Cancer, in press.
-
Lung Cancer
-
-
Shimokawa, H.1
Uramoto, H.2
Onitsuka, T.3
Iwata, T.4
Nakagawa, M.5
Ono, K.6
Hanagiri, T.7
-
4
-
-
49049109683
-
Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group
-
Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D and Le Chevalier T: Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26: 3552-3559, 2008.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3552-3559
-
-
Pignon, J.P.1
Tribodet, H.2
Scagliotti, G.V.3
Douillard, J.Y.4
Shepherd, F.A.5
Stephens, R.J.6
Dunant, A.7
Torri, V.8
Rosell, R.9
Seymour, L.10
Spiro, S.G.11
Rolland, E.12
Fossati, R.13
Aubert, D.14
Ding, K.15
Waller, D.16
Le Chevalier, T.17
-
5
-
-
33747847740
-
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): Randomized controlled trial
-
Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzáles-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorasso V, Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M and Hurteloup P: Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): randomized controlled trial. Lancet Oncol 7: 719-727, 2006.
-
(2006)
Lancet Oncol
, vol.7
, pp. 719-727
-
-
Douillard, J.Y.1
Rosell, R.2
De Lena, M.3
Carpagnano, F.4
Ramlau, R.5
Gonzáles-Larriba, J.L.6
Grodzki, T.7
Pereira, J.R.8
Le Groumellec, A.9
Lorasso, V.10
Clary, C.11
Torres, A.J.12
Dahabreh, J.13
Souquet, P.J.14
Astudillo, J.15
Fournel, P.16
Artal-Cortes, A.17
Jassem, J.18
Koubkova, L.19
His, P.20
Riggi, M.21
Hurteloup, P.22
more..
-
6
-
-
5444235920
-
Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
-
DOI 10.1200/JCO.2004.02.109
-
Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M and Tanimoto M: Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small cell lung cancer. J Clin Oncol 22: 3852-3859, 2004. (Pubitemid 41079865)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.19
, pp. 3852-3859
-
-
Hotta, K.1
Matsuo, K.2
Ueoka, H.3
Kiura, K.4
Tabata, M.5
Tanimoto, M.6
-
7
-
-
77955786290
-
Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer
-
Sugaya M, Uramoto H, Uchiyama A, Nagashima A, Nakanishi R, Sakata H, Nakanishi K, Hanagiri T and Yasumoto K: Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancer. Anticancer Res 30: 3039-3044, 2010.
-
(2010)
Anticancer Res
, vol.30
, pp. 3039-3044
-
-
Sugaya, M.1
Uramoto, H.2
Uchiyama, A.3
Nagashima, A.4
Nakanishi, R.5
Sakata, H.6
Nakanishi, K.7
Hanagiri, T.8
Yasumoto, K.9
-
8
-
-
10444237218
-
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum-containing regimens in advanced non-small cell lung cancer: A meta-analysis of survival outcomes
-
Le Chevalier T, Scagliotti G, Natale R, Danson S, Rosell R, Stahel R, Thomas P, Rudd RM, Vansteenkiste J, Thatcher N, Manegold C, Pujol JL, van Zandwijk N, Gridelli C, van Meerbeeck JP, Crino L, Brown A, Fitzgerald P, Aristides M and Schiller JH: Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum-containing regimens in advanced non-small cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer 47: 69-80, 2005.
-
(2005)
Lung Cancer
, vol.47
, pp. 69-80
-
-
Le Chevalier, T.1
Scagliotti, G.2
Natale, R.3
Danson, S.4
Rosell, R.5
Stahel, R.6
Thomas, P.7
Rudd, R.M.8
Vansteenkiste, J.9
Thatcher, N.10
Manegold, C.11
Pujol, J.L.12
Van Zandwijk, N.13
Gridelli, C.14
Van Meerbeeck, J.P.15
Crino, L.16
Brown, A.17
Fitzgerald, P.18
Aristides, M.19
Schiller, J.H.20
more..
-
9
-
-
16644398719
-
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group
-
Rudd RM, Gower NH, Spiro SG, Eisen TG, Harper PG, Littler JA, Hatton M, Johnson PW, Martin WM, Rankin EM, James LE, Gregory WM, Qian W and Lee SM: Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. J Clin Oncol 23: 142-153, 2005.
-
(2005)
J Clin Oncol
, vol.23
, pp. 142-153
-
-
Rudd, R.M.1
Gower, N.H.2
Spiro, S.G.3
Eisen, T.G.4
Harper, P.G.5
Littler, J.A.6
Hatton, M.7
Johnson, P.W.8
Martin, W.M.9
Rankin, E.M.10
James, L.E.11
Gregory, W.M.12
Qian, W.13
Lee, S.M.14
-
10
-
-
33746322562
-
Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104
-
DOI 10.1002/cncr.22024
-
Yamamoto N, Nakagawa K, Uejima H, Sugiura T, Takada Y, Negoro S, Matsui K, Kashii T, Takada M, Nakanishi Y, Kato T and Fukuoka M: Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104. Cancer 107: 599-605, 2006. (Pubitemid 44107221)
-
(2006)
Cancer
, vol.107
, Issue.3
, pp. 599-605
-
-
Yamamoto, N.1
Nakagawa, K.2
Uejima, H.3
Sugiura, T.4
Takada, Y.5
Negoro, S.-I.6
Matsui, K.7
Kashii, T.8
Takada, M.9
Nakanishi, Y.10
Kato, T.11
Fukuoka, M.12
-
11
-
-
78650244953
-
A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC)
-
Mancuso A, Igliorino MR, Martelli O, Belli R, Molfetta MD, Petris LD, Salvia RD and Marinis FD: A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 22: #7245, 2004.
-
(2004)
Proc Am Soc Clin Oncol
, vol.22
, Issue.7245
-
-
Mancuso, A.1
Igliorino, M.R.2
Martelli, O.3
Belli, R.4
Molfetta, M.D.5
Petris, L.D.6
Salvia, R.D.7
Marinis, F.D.8
-
12
-
-
0030912190
-
Revisions in the international system for staging lung cancer
-
Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997. (Pubitemid 27260107)
-
(1997)
Chest
, vol.111
, Issue.6
, pp. 1710-1717
-
-
Mountain, C.F.1
-
13
-
-
84958700139
-
A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small cell lung cancer (NSCLC) (final report)
-
Hasegawa Y, Takanashi S, Nakagawa H, Okudera K, Hayashi A, Morimoto T, Taima K and Okumura K: A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small cell lung cancer (NSCLC) (final report). Proc Am Soc Clin Oncol 23: #7333, 2005.
-
(2005)
Proc Am Soc Clin Oncol
, vol.23
, Issue.7333
-
-
Hasegawa, Y.1
Takanashi, S.2
Nakagawa, H.3
Okudera, K.4
Hayashi, A.5
Morimoto, T.6
Taima, K.7
Okumura, K.8
-
14
-
-
0024440650
-
Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
-
Calvert AH, Newell DR, Gumbrel LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME and Wiltshaw E: Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 17: 1748-1756, 1989.
-
(1989)
J Clin Oncol
, vol.17
, pp. 1748-1756
-
-
Calvert, A.H.1
Newell, D.R.2
Gumbrel, L.A.3
O'Reilly, S.4
Burnell, M.5
Boxall, F.E.6
Siddik, Z.H.7
Judson, I.R.8
Gore, M.E.9
Wiltshaw, E.10
-
15
-
-
0002953816
-
A computer program for estimation of creatine clearance from unstable serum creatine levels, age, sex and weight
-
Jellifie RW and Jelliffe SM: A computer program for estimation of creatine clearance from unstable serum creatine levels, age, sex and weight. Math Biosci 14: 17-24, 1972.
-
(1972)
Math Biosci
, vol.14
, pp. 17-24
-
-
Jellifie, R.W.1
Jelliffe, S.M.2
-
16
-
-
12344312699
-
-
Cancer Therapy Evaluation Program, Version 3.0, DCTD, NCI, NIH, DHHS
-
Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, 2003.
-
(2003)
Common Terminology Criteria for Adverse Events
-
-
-
17
-
-
0024536437
-
Optimal two-stage designs for phase II clinical trials
-
DOI 10.1016/0197-2456(89)90015-9
-
Simon R: Optical two-stage designs for phase II clinical trial. Control Clin Trials 10: 1-10, 1989. (Pubitemid 19099520)
-
(1989)
Controlled Clinical Trials
, vol.10
, Issue.1
, pp. 1-10
-
-
Simon, R.1
-
18
-
-
0042661285
-
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: A phase III randomized trial
-
Zatloukal P, Petrazelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtu H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T and Kůta M: Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial. Lung Cancer 41: 321-331, 2003.
-
(2003)
Lung Cancer
, vol.41
, pp. 321-331
-
-
Zatloukal, P.1
Petrazelka, L.2
Zemanová, M.3
Kolek, V.4
Skricková, J.5
Pesek, M.6
Fojtu, H.7
Grygárková, I.8
Sixtová, D.9
Roubec, J.10
Horenková, E.11
Havel, L.12
Průsa, P.13
Nováková, L.14
Skácel, T.15
Kůta, M.16
-
19
-
-
33847276516
-
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small cell lung cancer: Four-Arm Cooperative Study in Japan
-
Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y and Fukuoka M: Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18: 317-323, 2007.
-
(2007)
Ann Oncol
, vol.18
, pp. 317-323
-
-
Ohe, Y.1
Ohashi, Y.2
Kubota, K.3
Tamura, T.4
Nakagawa, K.5
Negoro, S.6
Nishiwaki, Y.7
Saijo, N.8
Ariyoshi, Y.9
Fukuoka, M.10
|